These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10639248)

  • 41. Hemoperfusion with a high-mobility group box 1 adsorption column can prevent the occurrence of hepatic ischemia-reperfusion injury in rats.
    Yamamoto T; Ono T; Ito T; Yamanoi A; Maruyama I; Tanaka T
    Crit Care Med; 2010 Mar; 38(3):879-85. PubMed ID: 20029346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury.
    Linkermann A; Bräsen JH; Himmerkus N; Liu S; Huber TB; Kunzendorf U; Krautwald S
    Kidney Int; 2012 Apr; 81(8):751-61. PubMed ID: 22237751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does reperfusion injury exist in humans?
    Kloner RA
    J Am Coll Cardiol; 1993 Feb; 21(2):537-45. PubMed ID: 8426022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of dantrolene in an in vivo and in vitro model of myocardial reperfusion injury.
    Preckel B; Schlack W; Comfère T; Thämer V
    Acta Anaesthesiol Scand; 2000 Feb; 44(2):194-201. PubMed ID: 10695914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Local and systemic coagulation marker response to musculocutaneous flap ischemia-reperfusion injury and remote ischemic conditioning: An experimental study in a porcine model.
    Krag AE; Hvas CL; Kiil BJ; Eschen GT; Damsgaard TE; Hvas AM
    Microsurgery; 2018 Sep; 38(6):690-697. PubMed ID: 29315844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioids and myocardial reperfusion injury.
    Gross GJ; Peart JN
    Arch Mal Coeur Vaiss; 2007 Mar; 100(3):231-7. PubMed ID: 17536429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blockade of the Na+-Ca2+ exchanger is more efficient than blockade of the Na+-H+ exchanger for protection of the myocardium from lethal reperfusion injury.
    Matsumoto T; Miura T; Miki T; Genda S; Shimamoto K
    Cardiovasc Drugs Ther; 2002 Jul; 16(4):295-301. PubMed ID: 12652098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocardial protection in reperfusion with postconditioning.
    Vinten-Johansen J; Zhao ZQ; Jiang R; Zatta AJ
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1035-45. PubMed ID: 16292995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Historical perspective on the pathology of myocardial ischemia/reperfusion injury.
    Jennings RB
    Circ Res; 2013 Aug; 113(4):428-38. PubMed ID: 23908330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [From ischemia to reperfusion lesions].
    Rochette L; Maupoil V
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():13-7. PubMed ID: 8304806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion.
    Buerke M; Rupprecht HJ; vom Dahl J; Terres W; Seyfarth M; Schultheiss HP; Richardt G; Sheehan FH; Drexler H
    Am J Cardiol; 1999 May; 83(10A):19G-22G. PubMed ID: 10482176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardioprotective effects of the novel selective endothelin-A receptor antagonist BSF 461314 in ischemia-reperfusion injury.
    Hansen A; Bekeredjian R; Filusch A; Wolf D; Gross ML; Mueller S; Korosoglou G; Kuecherer HF
    J Am Soc Echocardiogr; 2005 Nov; 18(11):1213-20. PubMed ID: 16275532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-time monitoring of cardiac metabolism using biosensors shows myocardial protection during ischemia-reperfusion injury with glucose-insulin-potassium administration.
    Eiferman D; Perez-Tamayo RA; Abe K; Okum E; Higgins R
    Surgery; 2007 Aug; 142(2):150-5. PubMed ID: 17689679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rho-kinase as a novel gene therapeutic target in treatment of cold ischemia/reperfusion-induced acute lethal liver injury: effect on hepatocellular NADPH oxidase system.
    Shiotani S; Shimada M; Taketomi A; Soejima Y; Yoshizumi T; Hashimoto K; Shimokawa H; Maehara Y
    Gene Ther; 2007 Oct; 14(19):1425-33. PubMed ID: 17671509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations.
    Monassier JP
    Arch Cardiovasc Dis; 2008; 101(7-8):491-500. PubMed ID: 18848692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondrial permeability transition pore and postconditioning.
    Gateau-Roesch O; Argaud L; Ovize M
    Cardiovasc Res; 2006 May; 70(2):264-73. PubMed ID: 16581044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ischemic heart disease and antioxidants: mechanistic aspects of oxidative injury and its prevention.
    Janero DR
    Crit Rev Food Sci Nutr; 1995 Jan; 35(1-2):65-81. PubMed ID: 7748481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prime causes of rapid cardiomyocyte death during reperfusion.
    Piper HM; García-Dorado D
    Ann Thorac Surg; 1999 Nov; 68(5):1913-9. PubMed ID: 10585103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Changes of miRNA-17-5p, miRNA-21 and miRNA-106a level during rat kidney ischemia-reperfusion injury].
    Ma L; Wu K; Liu K; Gu S; Wang Y; Xu Z; Yu X; Meng J
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(19):1488-92. PubMed ID: 26178499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.